We are live on ! Find out more
DC

Defender Capital Portfolio holdings

AUM $308M
1-Year Est. Return 4.52%
This Fund
S&P 500
This Quarter Est. Return
+11.46%
1 Year Est. Return
+4.52%
3 Year Est. Return
+83.48%
5 Year Est. Return
+78.82%
10 Year Est. Return
AUM
$294M
AUM Growth
+$9.02M
Cap. Flow
-$18.5M
Cap. Flow %
-6.29%
Top 10 Hldgs %
88.49%
Holding
41
New
5
Increased
9
Reduced
15
Closed
5

Sector Composition

1 Healthcare 24.37%
2 Technology 20.63%
3 Financials 14.27%
4 Consumer Staples 10.66%
5 Industrials 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VGSH icon
1
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
$56.3M 19.14%
968,975
-114,075
-11% -$6.63M
BRK.B icon
2
Berkshire Hathaway Class B
BRK.B
$1.06T
$41.6M 14.14%
98,874
-13,531
-12% -$5.32M
DHR icon
3
Danaher
DHR
$144B
$35M 11.9%
140,106
-10,779
-7% -$2.63M
STAA icon
4
STAAR Surgical
STAA
$1.3B
$28M 9.51%
730,387
+7,855
+1% +$255K
MNST icon
5
Monster Beverage
MNST
$94.5B
$22.5M 7.65%
379,407
+8,330
+2% +$479K
FTV icon
6
Fortive
FTV
$18.8B
$19.8M 6.73%
305,056
-41,051
-12% -$2.49M
TDY icon
7
Teledyne Technologies
TDY
$29.4B
$17.9M 6.07%
41,586
-4,184
-9% -$1.79M
PLTR icon
8
Palantir
PLTR
$322B
$14.1M 4.81%
614,477
+157,710
+35% +$3.36M
AXON
9
Axon Enterprise
AXON
$41.7B
$13.1M 4.45%
41,795
-2,468
-6% -$686K
VLTO icon
10
Veralto
VLTO
$23B
$12M 4.09%
135,464
-14,860
-10% -$1.23M
COST icon
11
Costco
COST
$415B
$8.58M 2.92%
11,708
-878
-7% -$627K
LCTX icon
12
Lineage Cell Therapeutics
LCTX
$297M
$7.35M 2.5%
4,967,675
-2,000
-0% -$2.27K
INTC icon
13
Intel
INTC
$485B
$5.28M 1.8%
119,485
+34,920
+41% +$1.56M
ESAB icon
14
ESAB
ESAB
$5.56B
$2.75M 0.93%
24,831
-2,717
-10% -$254K
NVDA icon
15
NVIDIA
NVDA
$4.94T
$1.27M 0.43%
14,050
+4,050
+41% +$294K
MSFT icon
16
Microsoft
MSFT
$2.94T
$1.09M 0.37%
2,593
-989
-28% -$400K
AMZN icon
17
Amazon
AMZN
$2.66T
$901K 0.31%
4,995
+15
+0.3% +$2.5K
AAPL icon
18
Apple
AAPL
$4.87T
$822K 0.28%
4,791
-159
-3% -$28.9K
CVX icon
19
Chevron
CVX
$372B
$631K 0.21%
+4,000
New +$604K
PFE icon
20
Pfizer
PFE
$142B
$498K 0.17%
17,955
+20
+0.1% +$555
ENOV icon
21
Enovis
ENOV
$1.55B
$468K 0.16%
7,500
-2,500
-25% -$150K
MLM icon
22
Martin Marietta Materials
MLM
$34B
$464K 0.16%
755
-195
-21% -$106K
IWM icon
23
iShares Russell 2000 ETF
IWM
$82.2B
$379K 0.13%
1,800
JPM icon
24
JPMorgan Chase
JPM
$912B
$370K 0.13%
1,849
PSX icon
25
Phillips 66
PSX
$82.3B
$339K 0.12%
2,073
+37
+2% +$5.33K

Similar funds

Defender Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Defender Capital held 41 positions worth $294M, up 3.2% from $285M the previous quarter. Its ten largest holdings account for 88% of the portfolio.

Defender Capital withdrew a net $18.5M in Q1 2024, closing 5 positions and reducing 15 holdings. Its most notable exit was ANI Pharmaceuticals, an estimated $1.32M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 23% a quarter earlier, followed by Technology and Financials.

Against the trend, Defender Capital opened a new position in Chevron worth $631K.

  • Defender Capital's largest Q1 2024 buy was Chevron: 4,000 shares worth $631K.
  • Defender Capital added most to Palantir in Q1 2024, an estimated $3.36M increase.
  • Defender Capital's biggest Q1 2024 reduction was Vanguard Short-Term Treasury ETF, cutting an estimated $6.63M.
  • Defender Capital fully exited ANI Pharmaceuticals in Q1 2024, selling an estimated $1.32M.
  • Defender Capital's ten largest holdings make up 88% of its $294M portfolio in Q1 2024.
  • Defender Capital opened 5 new positions and closed 5 in Q1 2024.
  • Defender Capital's portfolio value rose 3.2% quarter-over-quarter to $294M.

Based on Defender Capital's 13F filing for Q1 2024, filed 6 May 2024.